Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Australie (1)
Gap analysis
Neurology/Parkinson's Disease (1)
Start Up (3)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase III